Trial Profile
Double-blind, randomized, single-dose study to evaluate the atrial selectivity and safety of BMS-394136 in patients with implanted dual-chamber pacemakers or defibrillators
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2006
Price :
$35
*
At a glance
- Drugs BMS 394136 (Primary)
- Indications Arrhythmias
- Focus Pharmacodynamics
- 02 Nov 2006 Status change
- 21 Feb 2006 New trial record.